{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:35:30Z","timestamp":1791995730036,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humpath.2025.106029","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T23:24:29Z","timestamp":1767482669000},"page":"106029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Selected updates in thyroid, parathyroid, and adrenal gland pathology"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-2546","authenticated-orcid":false,"given":"Lori A.","family":"Erickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Torres-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.106029_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.humpath.2019.09.008","article-title":"Fifty years of thyroid pathology: concepts and developments","volume":"95","author":"Baloch","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","article-title":"Cribriform-morular thyroid carcinoma is a distinct thyroid malignancy of uncertain cytogenesis","volume":"32","author":"Boyraz","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.mayocp.2022.06.019","article-title":"Anaplastic thyroid carcinoma, squamous cell carcinoma pattern","volume":"97","author":"Gupta","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2025.106029_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12022-022-09718-0","article-title":"Grading of medullary thyroid carcinoma: an interobserver reproducibility study","volume":"33","author":"Williams","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of Parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2020.10.001","article-title":"Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the international collaboration on cancer reporting","volume":"110","author":"Giordano","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.humpath.2024.01.002","article-title":"Differentiated high grade thyroid carcinomas: diagnostic consideration and clinical features","volume":"144","author":"Tondi","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105674","article-title":"Clinically aggressive follicular cell-derived thyroid carcinoma: a comprehensive series with histomolecular characterization and discovery of novel gene fusions","volume":"153","author":"Alsugair","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12022-024-09842-z","article-title":"Clinicopathologic and molecular analysis of 15 pediatric and young adult patients with high-grade non-anaplastic thyroid carcinoma","volume":"35","author":"Whaley","year":"2024","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","article-title":"Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach","volume":"31","author":"Volante","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","article-title":"Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression","volume":"23","author":"Asioli","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/his.12246","article-title":"Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features","volume":"64","author":"Gnemmi","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106029_bib15","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa655","article-title":"The oncocytic variant of poorly differentiated thyroid carcinoma shows a specific immune-related gene expression profile","volume":"105","author":"Metovic","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/thy.2019.0263","article-title":"Prognostic significance of extent of invasion in poorly differentiated thyroid carcinoma","volume":"29","author":"Wong","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.humpath.2025.106029_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00428-022-03422-4","article-title":"Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience","volume":"482","author":"Xu","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106029_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAS.0b013e3181c46677","article-title":"Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases","volume":"34","author":"Asioli","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/his.14550","article-title":"Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases","volume":"80","author":"Xu","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106029_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2020.0668","article-title":"Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome","volume":"31","author":"Wong","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.humpath.2025.106029_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"key":"10.1016\/j.humpath.2025.106029_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","article-title":"Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism","volume":"15","author":"Masi","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2025.106029_bib23","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/BF03346439","article-title":"Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment","volume":"31","author":"Cetani","year":"2008","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.humpath.2025.106029_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","article-title":"Genomics and epigenomics in parathyroid neoplasia: from bench to surgical pathology practice","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","article-title":"Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours","volume":"459","author":"Juhlin","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106029_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humpath.2022.05.014","article-title":"Diagnostic significance of parafibromin expression in parathyroid carcinoma","volume":"127","author":"Gao","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","article-title":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the international Collaboration on Cancer Reporting","volume":"110","author":"Williams","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12022-018-9535-6","article-title":"Editorial: special issue on immunohistochemical biomarkers in endocrine pathology","volume":"29","author":"Erickson","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12022-019-09603-3","article-title":"Do you know the details of your PAX8 antibody? Monoclonal PAX8 (MRQ-50) is not expressed in a series of 45 medullary thyroid carcinomas","volume":"31","author":"Gucer","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000478-199903000-00007","article-title":"Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein","volume":"23","author":"Erickson","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAP.0000000000000019","article-title":"Adrenocortical carcinoma: review and update","volume":"21","author":"Erickson","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2016.08.006","article-title":"Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis","volume":"58","author":"Papathomas","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib34","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/PAS.0000000000001715","article-title":"Significance of Alpha-inhibin expression in Pheochromocytomas and paragangliomas","volume":"45","author":"Mete","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib35","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.mayocp.2021.03.032","article-title":"Angiosarcoma of the adrenal gland","volume":"96","author":"Erickson","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2025.106029_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/his.13255","article-title":"Challenges in surgical pathology of adrenocortical tumours","volume":"72","author":"Erickson","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106029_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106029_bib40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \"Helsinki Score\" in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib42","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/PAS.0b013e31822da401","article-title":"Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases","volume":"35","author":"Duregon","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-025-09867-y","article-title":"Reticulin framework assessment in neoplastic endocrine pathology","volume":"36","author":"Mortara","year":"2025","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/PAS.0000000000002174","article-title":"Diagnostic utility of a modified Reticulin algorithm in pediatric adrenocortical neoplasms","volume":"48","author":"Lopez-Nunez","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11154-025-09945-w","article-title":"The differential diagnosis of adrenocortical tumors: systematic review of Ki-67 and IGF2 and meta-analysis of Ki-67","volume":"26","author":"Oliveira","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.humpath.2025.106029_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1385\/EP:12:4:429","article-title":"Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms","volume":"12","author":"Erickson","year":"2001","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PAS.0000000000000574","article-title":"An international Ki67 reproducibility Study in adrenal cortical carcinoma","volume":"40","author":"Papathomas","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4103\/ijem.IJEM_573_16","article-title":"Diagnosis of adrenocortical tumors by Reticulin Algorithm","volume":"21","author":"Fonseca","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.pcr.0000175102.22075.54","article-title":"Oncocytic adrenocortical tumors","volume":"10","author":"Bisceglia","year":"2005","journal-title":"Pathol Case Rev"},{"key":"10.1016\/j.humpath.2025.106029_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000478-199805000-00012","article-title":"Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature","volume":"22","author":"Lin","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond--histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.humpath.2025.106029_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251328186","article-title":"Limitation of the current lin-weiss-bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the lin-weiss-bisceglia criteria","volume":"16","author":"Kim","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0b013e3181e2b726","article-title":"Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior","volume":"34","author":"Papotti","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-023-09767-z","article-title":"Pediatric adrenocortical neoplasms: a study comparing three histopathological scoring systems","volume":"34","author":"Jangir","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib57","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib58","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41379-018-0174-8","article-title":"Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review","volume":"32","author":"Picard","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12022-020-09654-x","article-title":"Clinical impact of pathological features including the Ki-67 labeling index on diagnosis and prognosis of adult and pediatric adrenocortical tumors","volume":"32","author":"Martins-Filho","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1530\/ERC-15-0086","article-title":"Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors","volume":"22","author":"Nielsen","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2025.106029_bib61","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.09.040","article-title":"Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults","volume":"351","author":"Faria","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/ERC-08-0237","article-title":"Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas","volume":"16","author":"Soon","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2025.106029_bib64","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2559.2006.02505.x","article-title":"IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours","volume":"49","author":"Schmitt","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106029_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical biomarkers of adrenal cortical neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1457496918822622","article-title":"Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: an important tool for improved patient follow-up","volume":"109","author":"Volpe","year":"2020","journal-title":"Scand J Surg"},{"key":"10.1016\/j.humpath.2025.106029_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.751770","article-title":"Immunohistochemical analysis of CYP11B2, CYP11B1 and beta-catenin helps subtyping and relates with clinical characteristics of unilateral primary aldosteronism","volume":"8","author":"Sun","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.humpath.2025.106029_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.14628","article-title":"Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism","volume":"96","author":"Ahn","year":"2022","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/cen.14958","article-title":"Immunohistochemical staining seems mandatory for individualizing and shortening follow-up in unilateral primary aldosteronism","volume":"99","author":"Gunnarsdottir","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib71","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1507\/endocrj.EJ22-0492","article-title":"Pathology and gene mutations of aldosterone-producing lesions","volume":"70","author":"Nishimoto","year":"2023","journal-title":"Endocr J"},{"key":"10.1016\/j.humpath.2025.106029_bib72","doi-asserted-by":"crossref","first-page":"e1582","DOI":"10.1210\/clinem\/dgad747","article-title":"Correlation of histopathologic subtypes of primary aldosteronism with clinical phenotypes and postsurgical outcomes","volume":"109","author":"Ahn","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib73","article-title":"Clinical significance of CYP11B2 immunostaining in unilateral primary aldosteronism","volume":"13","author":"Viukari","year":"2024","journal-title":"Endocr Connect"},{"key":"10.1016\/j.humpath.2025.106029_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.06.068","article-title":"Staining patterns of aldosterone synthase in patients undergoing surgery for primary aldosteronism: proposal for system of categorization and investigation of clinical and biochemical correlation","volume":"177","author":"MacDonald","year":"2025","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2025.106029_bib75","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2012-3726","article-title":"Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry","volume":"98","author":"Nanba","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106029_bib76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism","volume":"78","author":"Meyer","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.humpath.2025.106029_bib77","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/HYPERTENSIONAHA.123.22281","article-title":"Unilateral primary aldosteronism: long-term disease recurrence after adrenalectomy","volume":"81","author":"Tetti","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.humpath.2025.106029_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105876","article-title":"Subclassification of unilateral primary aldosteronism using an optimal cut-off value for positive CYP11B2 (aldosterone synthase) immunohistochemistry and modified histologic criteria in the Korean population","volume":"163","author":"Hong","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106029_bib79","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2174\/0115665240378395250416064732","article-title":"Immunohistochemical analysis of CYP11B2 (aldosterone synthase) and evaluation of the HISTALDO classification in patients with primary aldosteronism","volume":"25","author":"Karadepe","year":"2025","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.humpath.2025.106029_bib80","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ejendo\/lvaf118","article-title":"Histopathological evaluation based on CYP11B2 staining predicts outcomes in unilateral primary aldosteronism","volume":"192","author":"Goldbaum","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ejendo\/lvaf157","article-title":"Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics","volume":"193","author":"Solhuslokk Hose","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib82","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1161\/HYPERTENSIONAHA.122.19052","article-title":"Changes of the CYP11B2 expressing Zona Glomerulosa in human adrenals from birth to 40 years of Age","volume":"79","author":"van de Wiel","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.humpath.2025.106029_bib83","article-title":"Endocrine and neuroendocrine tumours","year":"2025","journal-title":"International Agency for Research on Cancer"},{"key":"10.1016\/j.humpath.2025.106029_bib84","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","article-title":"Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease","volume":"18","author":"Cavalcante","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.humpath.2025.106029_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-025-03554-1","article-title":"The mutational landscape of ARMC5 in primary Bilateral Macronodular Adrenal Hyperplasia: an update","volume":"20","author":"Bouys","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.humpath.2025.106029_bib86","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ejendo\/lvaf020","article-title":"Prevalence and main characteristics of primary aldosteronism in bilateral macronodular adrenal disease: a systematic review of the literature","volume":"192","author":"Panarelli","year":"2025","journal-title":"Eur J Endocrinol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:36:38Z","timestamp":1772724998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":86,"alternative-id":["S0046817725003168"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106029","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selected updates in thyroid, parathyroid, and adrenal gland pathology","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106029"}}